A PD-L1/2-PD-1-mediated immune checkpoint inhibition could be proposed to occur involving cells of (A) tumor and TME compartments, as well as (B) within different component cells of the TME (T-cells, CAFs, and macrophages) in EC. This evidence concerns the gene CD274 and neoplasm.